EMD-34871

Single-particle
3.63 Å
EMD-34871 Deposition: 29/11/2022
Map released: 04/10/2023
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-34871

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8hlb summary report (pdf.gz) Map-8hlb FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM structure of biparatopic antibody Bp109-92 in complex with TNFR2

EMD-34871

Single-particle
3.63 Å
EMD-34871 Deposition: 29/11/2022
Map released: 04/10/2023
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Escherichia coli (strain K12)
Sample: Cryo-EM structure of biparatopic antibody Bp109-92 in complex with TNFR2
Fitted models: 8hlb

Deposition Authors: Akiba H , Fujita J , Ise T , Nishiyama K , Miyata T , Kato T , Namba K , Ohno H , Kamada H , Nagata S , Tsumoto K
Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing signaling activity through epitope selection.
Akiba H , Fujita J , Ise T , Nishiyama K , Miyata T , Kato T , Namba K , Ohno H , Kamada H , Nagata S , Tsumoto K
(2023) Commun Biol , 6 , 987 - 987
PUBMED: 37758868
DOI: doi:10.1038/s42003-023-05326-8
ISSN: 2399-3642